← Leaderboards
Malaya B Chatterjee
University Of Cincinnati
$3,816,092
Attributed
$3,816,092
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $627.3K · FY2005–06$1M$750K$500K$250K$0
'05
'06
Funding mix
By agency
NIH$3,816,092 · 3
By mechanism
R01$3,816,092 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- Sunil Kumar Chatterjee$1,425,440
- Amy E Noffsinger$428,400
- Kenneth A Foon$1,472,072
- John C Byrd$38,019,882
- Eugene C. Somoza$36,549,732
Others in their field
Top investigators on “Neoplasm /Cancer Immunotherapy”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Charles A Coltman · Southwest Oncology Group$65,041,418
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Samuel A Wells · Duke University$32,148,803
- George Wilding · University Of Wisconsin Madison$22,104,400
Research focus
Neoplasm /Cancer ImmunotherapyNeoplasm /Cancer VaccineAntiidiotype AntibodyVaccine DevelopmentMonoclonal AntibodyNonhuman Therapy EvaluationLaboratory MouseEnzyme Linked Immunosorbent AssayCarcinoembryonal AntigenAthymic MouseBreast NeoplasmsEpidermal Growth FactorFlow CytometryGenetically Modified AnimalsGrowth Factor ReceptorsHuman TissueImmunocytochemistryLaboratory RabbitMacaca FascicularisAntitumor AntibodyProtooncogeneNeoplasm /Cancer TransplantationTransfection /Expression VectorCombination Cancer Therapy
Grant awards (12)
Rational Design of Therapeutic Vaccines for CEA+ Tumors$333,512
R01 · FY2006 · CA · contact PI
Rational Design of Therapeutic Vaccines for CEA+ Tumors$341,538
R01 · FY2005 · CA
HER 2/Neu--A Target For Cancer Immunotherapy$285,728
R01 · FY2005 · CA
Rational Design of Therapeutic Vaccines for CEA+ Tumors$341,538
R01 · FY2004 · CA
HER 2/Neu--A Target For Cancer Immunotherapy$285,728
R01 · FY2004 · CA
Rational Design of Therapeutic Vaccines for CEA+ Tumors$341,538
R01 · FY2003 · CA
HER 2/Neu--A Target For Cancer Immunotherapy$285,728
R01 · FY2003 · CA
ANTIIDIOTYPE VACCINE THERAPY OF HUMAN COLORECTAL CANCER$352,212
R01 · FY2002 · CA
HER 2/Neu--A Target For Cancer Immunotherapy$285,728
R01 · FY2002 · CA
ANTIIDIOTYPE VACCINE THERAPY OF HUMAN COLORECTAL CANCER$343,020
R01 · FY2001 · CA
HER 2/Neu--A Target For Cancer Immunotherapy$285,728
R01 · FY2001 · CA
ANTIIDIOTYPE VACCINE THERAPY OF HUMAN COLORECTAL CANCER$334,094
R01 · FY2000 · CA